Study aims to determine whether genes affect Plavix effectiveness

04/19/2010 | News & Observer (Raleigh, N.C.), The

Researchers at the University of North Carolina at Chapel Hill launched a study to determine whether heart patients carry a genetic trait that affects their response to blood thinner Plavix. The scientists hope the trial will help doctors screen patients who would benefit from the treatment and clarify a metabolism warning from the FDA.

View Full Article in:

News & Observer (Raleigh, N.C.), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Global Counsel - Advertising and Promotions
Mylan Inc.
Washington, DC